News

TiumBio, a clinical-stage biopharmaceutical company focused on discovering and developing innovative therapeutics for patients

Nexus Pharmaceuticals, LLC announced the launch of Tranexamic Acid. This milestone is another step for Nexus in its mission to provide

BioArctic AB announced today that the US FDA Office of Orphan Products Development (OOPD) has granted orphan drug designation

SIFI, a leading international pharmaceutical company specializing in ophthalmology, is pleased to announce a scientific collaboration

Argent BioPharma Ltd. a clinical-stage biopharmaceutical company addressing unmet medical needs by developing innovative treatments

MAXONA Pharmaceuticals today announced the preliminary results of the Phase 1 clinical program for MAX-001, which is in development as a New Molecular Entity

Oncorena is pleased to announce that the FDA has approved the Company's IND application to initiate the Phase I/II study Oncorella-1: A Phase 1/2

Clario, a leading provider of endpoint data solutions to the clinical trial industry, today announced they have acquired NeuroRx

Azurity Pharmaceuticals announced today the successful completion of its acquisition of Covis Group S.à r.l. ("Covis") from existing investors.

Skyhawk Therapeutics, Inc., a clinical-stage biotechnology company developing novel small molecule therapies designed to modulate critical RNA targets